Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order

Depo-Provera Meningioma Diagnosis Information Required to Qualify For Lawsuit

With a growing number of women filing Depo-Provera meningioma lawsuits, claiming that the quarterly birth control shot caused them to develop a brain tumor, the U.S. District Judge presiding over the litigation has outlined the required information that must be submitted to establish their diagnosis and the specific versions of the injection they received.

Although Depo-Provera has been on the market for more than three decades, and millions of women have received the birth control injections to help prevent pregnancy, the litigation began to emerge late last year, after studies detected a link between meningioma and Depo-Provera, with researchers now indicating that some women could face more than five times the risk of developing brain tumors.

Over the past six months, dozens of women have filed product liability lawsuits against Depo-Provera manufacturers, each raising similar allegations that women and the medical community were not adequately warned about the risks associated with the shots. However, as more women learn about the cause of their injuries, it is widely expected that thousands of claims may ultimately be filed.

To help effectively manage the litigation, the parties and court agreed late last month that all plaintiffs must provide initial documentary proof that they used versions of the Depo-Provera shot manufactured by each defendant named in the lawsuit, as well as meningioma diagnosis information, within 120 days of bringing the case.

Depo-Provera-Lawsuit-Settlement
Depo-Provera-Lawsuit-Settlement

Given common questions of fact and law raised in the cases, the U.S. Judicial Panel on Multidistrict Litigation (JPML) established a Depo-Provera meningioma MDL in February 2025, centralizing claims brought throughout the federal court system before U.S. District Judge M. Casey Rodgers in the Northern District of Florida, for coordinated discovery and pretrial proceedings.

Judge Rodgers is a veteran of large mass tort litigation, and has moved quickly to push the lawsuits over Depo-Provera brain tumors toward trial, indicating that a small group of pilot cases will move forward to help bring resolution to the litigation.

On March 14, Judge Rodgers issued a pretrial order (PDF), indicating that each plaintiff will be required to complete a Questionnaire, which certifies whether they currently have prescription, medical or pharmacy records establishing that they were administered the birth control shot, and the dates they were diagnosed with meningioma.

The order requires all cases filed on, or before, the order was issued and any future claims transferred to the MDL to fill out and return a Plaintiff Proof of Use/Injury Questionnaire within 120 days of the order, or from when they were transferred to the MDL.

“The Court understands that there may be cases in this MDL where Plaintiffs have requested prescription, medical insurance, and pharmacy records but lack definitive product identification,” Judge Rodgers noted. “The parties intend to confer and work out a separate proof of use/injury protocol for this situation. The parties’ proposed protocol on this issue is due within 14 days.”

How To File Depo-Provera Brain Tumor Lawsuit

As the litigation continues to move forward at a rapid pace, women are continuing to come forward each month to file claims to seek compensation for injuries suffered after taking the birth control injection. 

Depo-Provera meningioma lawyers are currently providing free consultations and claim evaluations for women throughout the U.S. who received the Depo-Provera injections and have been diagnosed with a meningioma, resulting in symptoms such as:

  • Persistent headaches
  • Dizziness
  • Memory loss

For no charge, these attorneys are helping women determine whether financial compensation may be available from drug makers who have failed to warn women about the serious health risks associated with the contraceptive.

To see if you qualify for a Depo-Provera brain tumor lawsuit, submit information about your claim to be reviewed by a team of Depo-Provera lawsuit lawyers. All Depo-shot lawsuits will be handled on a contingency fee basis, meaning there are no fees or expenses unless a settlement is obtained.

Image Credit: Shutterstock: Photo Nature Travel



0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025.
An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe.
Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer.